Aryl hydrocarbon receptor acts as a tumor suppressor in a syngeneic MC38 colon carcinoma tumor model
Hypoxia · 2019
DOI: 10.2147/hp.s196301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hypoxia, 2019. Verfasst von Poonam Yakkundi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Animal Biology Group, Bristol-Myers Squibb Company, Redwood City, CA, 94063, USA. Die Arbeit wurde bisher 14-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Animal Biology Group, Bristol-Myers Squibb Company, Redwood City, CA, 94063, USA.
- Immuno-Oncology Group, Bristol-Myers Squibb Company, Redwood City, CA, 94063, USA.
- Department of Pharmaceutics and Medicinal Chemistry, Thomas J Long School of Pharmacy & Health Sciences, University of the Pacific, Stockton, CA, 95211, USA.
Zitieren
APA
Yakkundi, P., Gonsalves, E., Galou-Lameyer, M., Selby, M. J., & Chan, W. K. (2019). Aryl hydrocarbon receptor acts as a tumor suppressor in a syngeneic MC38 colon carcinoma tumor model. Hypoxia. https://doi.org/10.2147/hp.s196301
Vancouver
Yakkundi P, Gonsalves E, Galou-Lameyer M, Selby MJ, Chan WK. Aryl hydrocarbon receptor acts as a tumor suppressor in a syngeneic MC38 colon carcinoma tumor model. Hypoxia. 2019. doi:10.2147/hp.s196301
BibTeX
@article{Yakkundi2019,
author = {Yakkundi, Poonam and Gonsalves, Eleanor and Galou-Lameyer, Maria and Selby, Mark J and Chan, William K},
title = {Aryl hydrocarbon receptor acts as a tumor suppressor in a syngeneic MC38 colon carcinoma tumor model},
journal = {Hypoxia},
year = {2019},
doi = {10.2147/hp.s196301}
}
EUVIMED